Wound Care Combination Product Line Expansion Is J&J/Ethicon Objective
This article was originally published in The Gray Sheet
Executive Summary
Johnson & Johnson/Ethicon's decision to focus on developing drug/device combination products for advanced wound care will result in U.S. market withdrawal of several older product lines